Skip to search formSkip to main contentSkip to account menu

Angiotensin-Converting Enzyme Inhibitors

Known as: Angiotensin Converting Enzyme Antagonists, Angiotensin I-Converting Enzyme Inhibitors, Inhibitors, Angiotensin-Converting Enzyme 
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting… 
National Institutes of Health

Related topics

Related topics

46 relations
Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme Inhibitors [MoA]Antihypertensive AgentsIn Blood

Narrower (37)

Benazepril hydrochloride 20 MG Oral TabletCaptoprilCaptopril / HydrochlorothiazideCilazapril

Broader (1)

Protease Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry
Hypertension or high blood pressure is one of the major independent risk factors for cardiovascular diseases. Angiotensin-I… 
Review
2007
Review
2007
Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production.
Food proteins contain latent biofunctional peptide sequences within their primary structures which may have the ability to exert… 
Highly Cited
2006
Highly Cited
2006
Inhibition of angiotensin converting enzyme activity by flavanol-rich foods.
Angiotensin converting enzyme (ACE) activity was evaluated in the presence of flavanol-rich foods, i.e., wines, chocolates, and… 
Review
2004
Review
2004
Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis
Background—Recently, statins and angiotensin-converting enzyme inhibitors (ACEIs) have been shown to slow aortic valve calcium… 
Highly Cited
1995
Highly Cited
1995
The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction
Background Left ventricular dilatation and neuroendocrine activation are common after acute anterior myocardial infarction. Long… 
Review
1995
Review
1995
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
From pharmacological investigations and clinical studies, it is known that ACE inhibitors exhibit additional local actions that… 
Review
1995
Review
1995
Tyrosine kinase inhibition: an approach to drug development.
Protein tyrosine kinases (PTKs) regulate cell proliferation, cell differentiation, and signaling processes in the cells of the… 
Review
1994
Review
1994
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
A ngiotensin-converting enzyme (ACE) inhibitors are commonly used drugs in the management of a variety of cardiovascular diseases… 
Highly Cited
1980
Highly Cited
1980
Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.
Among three biologically active substrates of angiotensin-converting enzyme, enzyme-binding affinities increase and chloride ion… 
Highly Cited
1978
Highly Cited
1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.
We investigated the antihypertensive effect of the angiotensin converting-enzyme inhibitor SQ 14225 in 12 hypertensive patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)